Abstract
Radiologic orbital imaging provides important information in the diagnosis and management of orbital inflammation. However, the diagnostic value of orbital imaging is not well elucidated. This study aimed to investigate the diagnostic accuracy of orbital imaging to diagnose orbital inflammatory diseases and its ability to detect active inflammation. We collected 75 scans of 52 patients (49 computed tomography (CT) scans; 26 magnetic resonance (MR) imaging scans). Clinical diagnoses included thyroid eye disease (TED) (41 scans, 31 patients), non-specific orbital inflammation (NSOI) (22 scans, 14 patients), sarcoidosis (4 scans, 3 patients), IgG4-related ophthalmic disease (IgG4-ROD) (5 scans, 3 patients), and granulomatosis with polyangiitis (GPA) (3 scans, 1 patient). Two experienced neuroradiologists interpreted the scans, offered a most likely diagnosis, and assessed the activity of inflammation, blinded to clinical findings. The accuracy rate of radiological diagnosis compared to each clinical diagnosis was evaluated. Sensitivity and specificity in detecting active inflammation were analyzed for TED and NSOI. The accuracy rate of radiologic diagnosis was 80.0% for IgG4-ROD, 77.3% for NSOI, and 73.2% for TED. Orbital imaging could not diagnose sarcoidosis. Orbital CT had a sensitivity of 50.0% and a specificity of 75.0% to predict active TED using clinical assessment as the gold standard. The sensitivity/specificity of orbital MR was 83.3/16.7% for the detection of active NSOI. In conclusion, orbital imaging is accurate for the diagnosis of IgG4, NSOI, and TED. Further studies with a large number of cases are needed to confirm this finding, especially with regard to uncommon diseases. Orbital CT showed moderate sensitivity and good specificity for identifying active TED.
| Original language | English (US) |
|---|---|
| Article number | 21875 |
| Journal | Scientific Reports |
| Volume | 10 |
| Issue number | 1 |
| DOIs | |
| State | Published - Dec 1 2020 |
Funding
This research was supported by the US National Institutes of Health National Eye Institute: EY020249, EY010572; Research to Prevent Blindness; Grandmaison Fund for Autoimmunity Research; the Stan and Madelle Rosenfeld Family Trust; and the William and Mary Bauman Foundation. The funding sources played no role in the design of the study; collection, analysis, and interpretation of data; in writing of the report; or in the decision to submit the article for publication. Roger A. Dailey and John D. Ng are consultants to Bio-logic Aqua Research Inc.; James T. Rosenbaum is a consultant to Janssen, Abbvie, Roche, UpToDate, Novartis, Gilead, UCB, Santen, Horizon, Corvus, Celldex and Eyevensys, and has received research funding from Alcon Research Institute and Pfizer. The following authors have no financial disclosures: Min Joung Lee, Bronwyn E. Hamilton, David Pettersson, Kimberly Ogle, Jennifer Murdock, Eric A. Steele, Rohan Verma, Stephen R. Planck, Tammy M. Martin, Dongseok Choi.
| Funders | Funder number |
|---|---|
| Stan and Madelle Rosenfeld Family Trust | |
| US National Institutes of Health National Eye Institute | |
| William and Mary Bauman Foundation | |
| National Eye Institute and Casey Eye Institute | EY010572, R01EY020249 |
| Research to Prevent Blindness | |
| Pfizer | |
| Gilead Sciences | |
| Alcon Research Institute |
ASJC Scopus subject areas
- General
Fingerprint
Dive into the research topics of 'Radiologic imaging shows variable accuracy in diagnosing orbital inflammatory disease and assessing its activity'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS